Professor Clare Turnbull is Professor of Translational Cancer Genetics in the Division of Genetics and Epidemiology at the Institute of Cancer Research, London. Her research spans statistical, population and public-health-related analyses of genetic cancer susceptibility and implementation of expanded genomic testing. She is currently rolling out a new £4.3 million Cancer Research UK(CRUK)-funded program: ‘CanGene-CanVar: Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer’ program. As an honorary consultant in Public Health, she is working closely with Public Health England in this program to incorporate genomic data into the National Cancer Registration datasets. She is also in process of initiating BRCA-DIRECT: a CRUK-funded program to develop and pilot a digital platform to deliver BRCA testing, enabling extension of testing to all women with breast cancer. Professor Turnbull undertook her preclinical training in Cambridge and qualified in medicine from The University of Oxford. She undertook general medical training across hospitals in Oxford and London and specialist training in Clinical Genetics in London. She completed a PhD in Genetic Epidemiology and Molecular Genetics at the ICR and a Masters degree in Epidemiology and Statistics at the London School of Hygiene and Tropical Medicine. She is a member by distinction of the Faculty of Public Health Medicine and a fellow of both the Royal College of Pathologists and Royal College of Physicians.